Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | NR4T5 | — |
Administration of diluent alone; Administration of diluent alone; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number NR4T5) for prophylaxis. On 08-AUG-2025, the patient received Shingrix. On 08-AUG-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Administration of diluent alone) and inappropriate dose of vaccine administered (Verbatim: Administration of diluent alone). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 17-SEP-2025 On 17th September 2025, a registered nurse called and reported that they had wanted information regarding the Shingrix vaccine and had only administered the diluent.